Berson Gianco's CAR-T clinical application was accepted January 03, 2018 Source: Yaodutoutou On January 2, 2018, Anhui Anke Bioengineering (Group) Co., Ltd. participated in the company Berson Gianke Cell Technology Co., Ltd. received the "Notice of Acceptance" from the State Administration of Food and Drug Administration Administrative License Document, submitted by Boshi Gianke The application for clinical trial of CAR-T therapy "targeting CD19 autologous chimeric antigen receptor T cell infusion" was accepted by the State Food and Drug Administration on December 28, 2017, and the acceptance number is: CXSL1700216. Chimeric antigen receptor T cells (abbreviation: CAR-T) is a novel immunotherapy that represents the latest development trend in cancer therapy. This technology is a single-chain antibody gene that targets tumor antigens and a signal molecule that activates T cell activity and promotes T cell survival. It is expressed on the patient's peripheral T lymphocytes through a gene modification strategy, thereby treating the patient's T lymphocytes. The cells are transformed into drugs that specifically kill tumors. In international and domestic related clinical trials, it has shown great lethality and clinical efficacy for specific tumor types. The CAR-T drug accepted by Berson Gianco is a therapy against B cell acute lymphoblastic leukemia (B-ALL) targeting CD19 molecule. Boss Gianke is not only committed to the development of cellular immunotherapy products for the treatment of hematological tumor B-ALL, but also actively carries out CAR for T-cell acute lymphoblastic leukemia (T-ALL) and solid tumors such as lung cancer and pancreatic cancer. -T product development. Berson Gianco has established a 2,000-square-meter CAR-T cell production workshop and a complete quality control system and quality control facilities and equipment that meet the GMP requirements, which can fully meet the clinical test requirements of CAR-T cell products.
PTZ: In the security monitoring application, it is the abbreviation of Pan/Tilt/Zoom, representing the pan tilt omnidirectional (up and down, left and right) movement, lens zoom and zoom control.
China Camera System, we offered that you can trust. Welcome to do business with us.
Camera System,Home Security Camera System Wireless,Network Camera System,8 Channel Poe Camera System Shenzhen Fuvision Electronics Co., Ltd. , https://www.outdoorsolarcameras.com
Fuvision's autonomous automatic PTZ intelligent tracking enables the camera to automatically PTZ drive its own PTZ and zoom lens, and automatically controls the PTZ Camera to rotate the PTZ in all directions and zoom the lens. It also conducts visual oriented automatic tracking for the locked moving target to ensure that the tracking target continues to appear in the center of the lens with a close-up image, so that the guards can see the information more clearly, It can also be used for obtaining evidence afterwards. The automatic PTZ tracking module makes up for the narrow field of vision of fixed camera monitoring, which is an essential function of a perfect security monitoring system.
The intelligent vision PTZ automatic tracking and monitoring system has the target analysis function, and is equipped with a high-resolution camera, a large magnification optical zoom lens and a high speed PTZ, which can automatically capture suspicious targets quickly and accurately. By setting the preset position intelligent vision PTZ automatic tracking monitoring system, the preset position scanning, automatic cruise and other functions can be realized, and many special requirements of intelligent monitoring can also be realized. In addition, the intelligent vision PTZ automatic tracking and monitoring system also has the advantages of beautiful appearance and strong concealment, so it is very suitable for public security intelligent monitoring applications in airports, squares, rail transit, villas, government administrative units, military regions, museums and other types of places.